Академический Документы
Профессиональный Документы
Культура Документы
3. Kumar V, Abbas AK, Nelson F, Mitchell RN. Robbins Basic Pathology. 1st
4. Sean WP, Koppe, Marc E, Richard H, Moseley, Richard M. at al. Trans fat
6. Martinez MG, Garcia VE, Anell MV, Cravioto MG, Gonzalez, Alvarenga JC.
at al. Dietary trans fatty acids and its metabolic implications. Gac Med Mex
2010: 146(4):281-8.
64
7. Sartika RAD. Pengaruh Asupan Asam Lemak Trans terhadap Profil Lipid
of high fat diet with different trans fatty acid levels differentially induces
oxidative stress and non alcoholic fatty liver disease (NAFLD) in rats. Nutr
10. Buja LM, Krueger GRF. Netter's Illustrated Human Pathology. 1st ed. New
11. Anderson JR. Muir's Textbook of Pathology. 11th ed. London. ELBS; 1983
12. Gray H, F.R.S. Gray's Anatomy. 10th ed. London. Constable & Robinson Ltd;
2002
13. Sherlock S. Penyakit Hati dan Sistem Empedu. 2nd ed. Jakarta. Widya
15. Arthur C. Guyton, John E Hall. Buku Ajar Fisiologi Kedokteran . 1st ed.
65
16. Mozaffarian D, Katan MB, Ascherio A, Stampfer M, Willett WC. Trans Fatty
17. Murray, RK. Biokimia Harper edisi 25. Jakarta. EGC. 2005
18. Ascherio A, Willett WC. Health effects of trans fatty acids. Am J Clin Nutr.
1997;66(4): 1006S-10
19. Stender S, Jorn D. The influence of trans fatty acids on health: A report from
20. Brehm BJ. Trans- Fatty Acids : Coming Soon to Your Food Labels. In Diet
21. Inis SM. The Trans Fatty Acid Composition and Content of Canadian Foods
22. Sartika RAD. Pengaruh suhu dan lama proses menggoreng (deep frying)
23. Ketaren S. Pengantar teknologi minyak dan lemak pangan. Jakarta: Penerbit
24. Puspitasari NN. Asam lemak trans dalam makanan: Mekanisme pembentukan
1996;7:84-94
66
25. Warner K. Chemistry of frying oils. In: Akoh CC & David BM, editor. Food
2000.p.169-298
26. Abbas AK, Litcman AH. Basic Immunology Update 2nd Ed. Philadelpia: WB
27. Zivkovic AM, German JB and Sanyal AJ. Comparative review of diets for the
28. Madge LA, Pober JS. TNF signaling in vascular endothelial cells. Exp Mol
Pathol. 2001;70:317–25.
29. Grimble RF, Tappia PS. Modulatory influence of unsaturated fatty acids on
1995;23:282–7.
30. Das UN. Is metabolic syndrome X an inflammatory condition? Exp Biol Med.
2002;227:989–97.
32. Abd El-Mageed NM. Hepatoprotective effect of feeding celery leaves mixed
67
33. Reid Robin, Fiona Roberts. Pathology Illustrated. 6th ed. New York. Elsevier
34. Lentsch AB, Ward PA: Regulation of inflammatory vascular damage. J Pathol
190:343, 2000.
35. Luster AD, Alon R, von Andrian UH: Immune cell migration in
6:1182,2005.
37. Serhan CN, Savill J: Resolution o inflammation: the beginning programs the
39. Stevens A, Lowe J. Human Histolgy, 3th ed. Philadelphia: Elsevier Mosby.
2005.
2002.
42. Budiwiyono, Imam. Buku Ajar Patologi Klinik. Semarang: Bagian Patologi
68
LAMPIRAN 1
69
LAMPIRAN 2.
70
Jumlah Sel Neutrofil Per-Lapangan Pandang Besar
Rata-
Kelompok 1 2 3 4 5 Rata
Neutrofil
K
1 6 5 7 8 9 7
2 7 2 2 7 6 4.8
3 7 6 6 4 5 5.6
4 6 7 5 9 1 5.6
5 9 5 11 5 3 6.6
6 6 3 5 7 5 5.2
P1
1 7 7 11 10 3 7.6
2 6 5 7 7 5 6
3 7 8 6 9 12 8.4
4 8 9 12 7 9 9
5 7 8 10 9 12 9.2
6 5 7 5 6 8 6.2
P2
1 8 10 14 16 15 12.6
2 14 15 8 9 7 10.6
3 10 9 7 9 11 9.2
4 8 7 9 10 10 8.8
5 10 9 12 8 9 9.6
6 9 7 5 9 6 7.2
71
Jumlah Sel Radang Per-Lapangan Pandang
Besar
Kelompok 1 2 3 4 5 Rata-Rata
Sel Radang
K
1 36 36 38 29 32 34.2
2 43 30 32 29 27 32.2
3 35 38 34 32 28 33.4
4 29 19 29 29 26 26.4
5 32 27 35 25 28 29.4
6 43 34 26 41 27 34.2
P1
1 45 50 53 59 44 50.2
2 34 34 41 45 43 39.4
3 28 49 41 52 53 44.6
4 40 46 30 37 52 41
5 39 45 28 39 44 39
6 48 49 25 42 41 41
P2
1 54 53 61 68 52 57.6
2 42 45 35 39 39 40
3 82 66 52 62 76 67.6
4 50 59 64 43 68 56.8
5 52 68 71 42 64 59.4
6 66 70 67 64 67 66.8
72
LAMPIRAN 3.
1. Sel Limfosit
a. Analisis Deskriptif
Descriptives
Median 27.300
Variance 10.551
Minimum 20.8
Maximum 29.0
Range 8.2
P1 Median 34.100
Variance 19.520
Minimum 29.8
Maximum 42.6
73
Range 12.8
Median 48.900
Variance 120.023
Minimum 29.4
Maximum 59.6
Range 30.2
b. Uji Normalitas
Tests of Normality
a
Kelompok Kolmogorov-Smirnov Shapiro-Wilk
c. Uji Homogenitas
ANOVA
Rata-rata Limfosit
e. Uji Post-Hoc
Multiple Comparisons
Dependent Variable: Rata-rata Limfosit
LSD
(I) Kelompok (J) Kelompok Mean Std. Error Sig. 95% Confidence Interval
Difference (I-J) Lower Bound Upper Bound
*
P1 -8.9667 4.0838 .044 -17.671 -.262
Kontrol *
P2 -22.5333 4.0838 .000 -31.238 -13.829
*
Kontrol 8.9667 4.0838 .044 .262 17.671
P1 *
P2 -13.5667 4.0838 .005 -22.271 -4.862
*
Kontrol 22.5333 4.0838 .000 13.829 31.238
P2 *
P1 13.5667 4.0838 .005 4.862 22.271
75
2. Sel Neutrofil
a. Analisis Deskriptif
Descriptives
Median 5.600
Variance .704
Minimum 4.8
Maximum 7.0
Range 2.2
Median 8.000
Variance 1.915
P1
Std. Deviation 1.3837
Minimum 6.0
Maximum 9.2
Range 3.2
76
Kurtosis -2.058 1.741
Median 9.400
Variance 3.307
Minimum 7.2
Maximum 12.6
Range 5.4
b. Uji Normalitas
Tests of Normality
a
Kelompok Kolmogorov-Smirnov Shapiro-Wilk
c. Uji Homogenitas
1.016 2 15 .386
77
d. Uji One Way Anova
ANOVA
Rata-rata Neutrofil
e. Uji Post-Hoc
Multiple Comparisons
Dependent Variable: Rata-rata Neutrofil
LSD
(I) Kelompok (J) Kelompok Mean Std. Error Sig. 95% Confidence Interval
Difference (I-J) Lower Bound Upper Bound
*
P1 -1.9333 .8114 .031 -3.663 -.204
Kontrol *
P2 -3.8667 .8114 .000 -5.596 -2.137
*
Kontrol 1.9333 .8114 .031 .204 3.663
P1 *
P2 -1.9333 .8114 .031 -3.663 -.204
*
Kontrol 3.8667 .8114 .000 2.137 5.596
P2 *
P1 1.9333 .8114 .031 .204 3.663
78
3. Sel Radang
a. Analisis Deskriptif
Descriptives
Median 32.800
Variance 9.799
Minimum 26.4
Maximum 34.2
Range 7.8
Median 41.000
Variance 18.011
P1
Std. Deviation 4.2439
Minimum 39.0
Maximum 50.2
Range 11.2
79
Kurtosis 1.813 1.741
Median 58.500
Variance 99.431
Minimum 40.0
Maximum 67.6
Range 27.6
b. Uji Normalitas
Tests of Normality
a
Kelompok Kolmogorov-Smirnov Shapiro-Wilk
c. Uji Homogenitas
1.528 2 15 .249
80
d. Uji One Way Anova
ANOVA
Rata-rata Sel Radang
e. Uji Post-Hoc
Multiple Comparisons
Dependent Variable: Rata-rata Sel Radang
LSD
(I) Kelompok (J) Kelompok Mean Std. Error Sig. 95% Confidence Interval
Difference (I-J) Lower Bound Upper Bound
*
P1 -10.9000 3.7600 .011 -18.914 -2.886
Kontrol *
P2 -26.4000 3.7600 .000 -34.414 -18.386
*
Kontrol 10.9000 3.7600 .011 2.886 18.914
P1 *
P2 -15.5000 3.7600 .001 -23.514 -7.486
*
Kontrol 26.4000 3.7600 .000 18.386 34.414
P2 *
P1 15.5000 3.7600 .001 7.486 23.514
81
LAMPIRAN 4.
DOKUMENTASI PENELITIAN
82
Kondisi laboratorium penelitian Kandang individual tikus percobaan
83
LAMPIRAN 5
Identitas
NIM : G2A009041
Keanggotaan Organisasi
84
4. Sie Dokumentasi Scientific Fair 2011
2. Lisa Lestari
3. Ericko H. Laymena
dihydrochloride
85